Phytopharmaceuticals in India 2024: A fusion oftradition and modern science

The phytopharmaceutical sector in India is witnessing a surge in growth in 2024, driven by regulatory support, technological advancements, and a convergence of traditional knowledge with modern science. Phytopharmaceuticals, defined as standardized plant-based drugs with multiple bioactive compounds, are subject to rigorous scientific evaluation, aligning India's regulatory framework with international standards like the FDA's botanical drug guidelines. Recent innovations, particularly in nanotechnology, have improved the bioavailability and therapeutic efficacy of phytopharmaceuticals, with promising applications in cancer treatment. The Indian government’s supportive regulations, introduced in 2015, have fostered innovation, leading to increased research and investment in this field. Indian researchers are also leveraging indigenous knowledge from traditional systems like Ayurveda to validate and develop new therapies, including promising developments with turmericbased phytopharmaceuticals such as Curcumin. These advancements highlight India's growing influence in the global phytopharmaceutical market, as it integrates traditional medicine with cuttingedge research to develop novel plant-based drugs.